Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Hanna Bandos(NRG Oncology)
JNCI Cancer Spectrum
April 1, 2025
Cited by 2


Related Papers

No related papers found

Powered by citation graph analysis